Case number 2017-2486
Pozen, Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 6, 2019 | 6 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [626426] [17-2473, 17-2481, 17-2484, 17-2486, 17-2489, 17-2491, 17-2492, 17-2493] [JAB] [Entered: 08/06/2019 04:04 PM] (2) |
| May 15, 2019 | 4 | OPINION filed for the court by Prost, Chief Judge; Clevenger, Circuit Judge and Wallach, Circuit Judge. Precedential Opinion. [607400] [17-2473, 17-2481, 17-2484, 17-2486, 17-2489, 17-2491, 17-2492, 17-2493] [JAB] [Entered: 05/15/2019 09:42 AM] (25) |
| May 15, 2019 | 5 | JUDGMENT filed. REVERSED as to 17-2473, 17-2481, 17-2484, 17-2486; DISMISSED as to 17-2489, 17-2491, 17-2492, 17-2493. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [607402] [17-2473, 17-2481, 17-2484, 17-2486, 17-2489, 17-2491, 17-2492, 17-2493] [JAB] [Entered: 05/15/2019 09:44 AM] (2) |
| Feb 25, 2019 | 3 | ORDER filed granting motion to reschedule argument [588056-2] filed by Cross-Appellants Horizon Pharma, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company in 17-2473. By: Per Curiam. Service as of this date by the Clerk of Court. [588252] [17-2473, 17-2481, 17-2484, 17-2486, 17-2487, 17-2488, 17-2489, 17-2491, 17-2492, 17-2493] [PBC] [Entered: 02/25/2019 09:19 AM] (2) |
| Aug 25, 2017 | 1 | Appeal docketed. Received: 08/21/2017. [456666] [JB] [Entered: 08/25/2017 12:12 PM] (27) |
| Aug 25, 2017 | 2 | Note to file: The following cases are consolidated: 17-2473 Lead with 17-2481,17-2484, 17-2486, 17-2487, 17-2488 (MEMBER CASES) and 17-2489, 17-2491, 17-2492, 17-2493 (CROSS-APPEALS). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [456764] [JB] [Entered: 08/25/2017 03:08 PM] (0) |
